Fortress Biotech (FBIO) Operating Margin Growth (1y) (2016 - 2026)
Powered by 
Analysis
Fortress Biotech (FBIO) Operating Margin Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 7,666.00 |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 1,238.00 |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 2,002.00 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -1,651.00 |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 29,091.00 |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | 16,876.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16,876.00 |
| Dec 31, 2025 | 12,785.00 |
| Sep 30, 2025 | 11,240.00 |
| Jun 30, 2025 | -3,567.00 |
| Mar 31, 2025 | 11,078.00 |
| Dec 31, 2024 | -5,930.00 |
| Sep 30, 2024 | -11,145.00 |
| Jun 30, 2024 | 10,164.00 |
| Mar 31, 2024 | 19,300.00 |
| Dec 31, 2023 | 23,472.00 |
| Sep 30, 2023 | 26,737.00 |
| Jun 30, 2023 | -892.00 |
| Mar 31, 2023 | -27,605.00 |
| Dec 31, 2022 | 620.00 |
| Sep 30, 2022 | -7,019.00 |
| Jun 30, 2022 | -3,909.00 |
| Mar 31, 2022 | 6,148.00 |
| Dec 31, 2021 | -16,249.00 |
| Sep 30, 2021 | 643.00 |
| Jun 30, 2021 | 2,835.00 |